Leerink maintains Outperform rating on OmniAb
The broker reiterated its Outperform stance on OmniAb, but no new financials, guidance, or quantified targets were provided in the supplied report.
The broker reiterated its Outperform stance on OmniAb, but no new financials, guidance, or quantified targets were provided in the supplied report.